SEC Tracker
Get the app

Helus Pharma

HELP on Nasdaq, formerly CYBNPharmaceutical preparations

Helus Pharma’s latest filing is a 6-K from . Every Helus Pharma filing is below, newest first.

Insiders 4 insiders bought $9.7M of Helus Pharma stock on the open market in the last 90 days. Every trade

Get email alertsGet the app
Legal name
Helus Pharma Inc.
CIK
1833141

6-K filed

Helus Pharma to participate in Guggenheim Healthcare Innovation Conference

  • CEO Michael Halstead to participate in a fireside chat on November 9, 2026 at 3:00 p.m. EDT.
  • Company is a clinical-stage pharmaceutical company focused on mental health treatments.

Read the 6-K on EDGARTables over time

Get an email when Helus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

All filings

Latest: the 48 newest filings, key filings first. Each other tab counts its kind among the 398 most recent EDGAR filings.

Results, 8-Ks and Major or Notable filings come first, then registrations and share actions, then everything else, newest first. Routine filings are kept here unmarked; insider filings are summed up in one line.

Results, 8-Ks and key filings

4 insiders bought $9.7M of Helus Pharma stock on the open market in the last 90 days. Every HELP insider trade

Other filings

  9. 6 more 6-K filings, Sep 22 to Sep 3
  10. 11 older filings, Sep 2 to Jul 21
    10. 2 more 6-K filings, Aug 3 to Jul 21

Older filings on EDGAR

Results 6

DateFormWhat it is
Jun 29, 202640-FYear ended Mar 31, 2026
Jul 1, 202540-FYear ended Mar 31, 2025
Jun 26, 202440-FYear ended Mar 31, 2024
Jun 27, 202340-FYear ended Mar 31, 2023
Jul 22, 202240-F/AYear ended Mar 31, 2022 (amended)
Jun 22, 202240-FYear ended Mar 31, 2022

Offerings and dilution 7

DateFormWhat it is
Sep 1, 2026S-8Employee stock plan registration
Jun 24, 2026FWPOffering term sheet
Oct 28, 2025FWPOffering term sheet
Oct 28, 2025FWPOffering term sheet
Oct 28, 2025FWPOffering term sheet
Jan 14, 2025EFFECTRegistration declared effective
Jan 3, 2024EFFECTRegistration declared effective

Insiders 20

DateFormWhat it is
Nov 2, 2026Form 3New insider
Oct 26, 2026Form 3New insider
Oct 23, 2026Form 3New insider
Oct 23, 2026Form 3New insider
Oct 23, 2026Form 3New insider
Oct 1, 2026Form 4Eric H. L. So (Director) received 248,000 HELP
Oct 1, 2026Form 4Greg Cavers (CFO) bought 3,000 HELP at $12.91, worth $39K
Oct 1, 2026Form 3New insider

12 older insiders filings on EDGAR.

Ownership 32

DateFormWhat it is
Sep 9, 2026Schedule 13DActive stake of 5% or more
Sep 9, 2026Schedule 13DActive stake of 5% or more
Aug 14, 2026Schedule 13G/APassive stake of 5% or more (amended)
Aug 12, 2026Schedule 13GPassive stake of 5% or more
May 15, 2026Schedule 13G/APassive stake of 5% or more (amended)
May 15, 2026Schedule 13GPassive stake of 5% or more
Apr 22, 2026Schedule 13G/APassive stake of 5% or more (amended)
Apr 10, 2026Schedule 13GPassive stake of 5% or more

24 older ownership filings on EDGAR.

Other 332

DateFormWhat it is
Nov 3, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 27, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 21, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 15, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 8, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 5, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 2, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

Oct 1, 20266-KForeign issuer report

Key exhibits: Press release (EX-99.1)

324 older other filings on EDGAR.

Listing compliance

No listing notices in the 8-K item 3.01 filings SEC Tracker has read.

Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. All open notices

Trading halts

No trading halts for HELP since Feb 22, 2019, when SEC Tracker began reading the Nasdaq Trader feed.

Halt times and codes from the Nasdaq Trader trade halts feed, which lists Nasdaq and other exchange halts. Filings matched by SEC Tracker from EDGAR by company and time. Not investment advice. All recent halts

Fails-to-deliver: 6,284 shares on Aug 25, 2026, per SEC data

Helus Pharma shares and listing

From the company's own filings; each row names its source. Not investment advice.

  • Listing compliance8-K item 3.01No noticesin the filings read

Insider activity

4 insiders bought $9.7M of Helus Pharma stock on the open market in the last 90 days.

  • CFO bought $39K
  • CEO bought $1.3M
  • Chief Growth Officer bought $2.5M

All HELP insider trades

Stakes Helus Pharma reports in other companies

Filings Helus Pharma made as a holder or insider of another company. They are about that company, not Helus Pharma.

Similar companies

Same SIC code (2834 Pharmaceutical preparations) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX